Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

54.23 -1.47 (-2.64%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,008,942
Open	56.14
Bid (Size)	54.15 (100)
Ask (Size)	54.99 (100)
Prev. Close	55.70
Today's Range	53.92 - 56.39
52wk Range	44.12 - 78.48
Shares Outstanding	78,935,098
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ↗

September 24, 2026

One is burning cash while chasing gene-editing breakthroughs. The other generates billions from a single therapy. Their divergent paths reveal starkly different risk-reward profiles.

Via The Motley Fool

3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026 ↗

September 20, 2026

Don't read too much into this year's lackluster performance. Near-term catalysts are firming up.

Via The Motley Fool

Performance

YTD	+0.9%	+0.9%
1 Month	-8.4%	-8.4%
3 Month	-1.3%	-1.3%
6 Month	+18.5%	+18.5%
1 Year	-10.1%	-10.1%

More News

Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? ↗

September 17, 2026

Via The Motley Fool

CRISPR Therapeutics Eyes CASGEVY Growth, Year-End Pipeline Catalysts ↗

September 14, 2026

Via MarketBeat

AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗

September 14, 2026

Via The Motley Fool

Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗

September 11, 2026

Via The Motley Fool

Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗

September 11, 2026

Via The Motley Fool

Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September ↗

September 11, 2026

Via The Motley Fool

Why CRISPR Therapeutics Stock Rocked the Market Last Month ↗

September 08, 2026

Via The Motley Fool

Where Will CRISPR Therapeutics Stock Be in 5 Years? ↗

September 08, 2026

Via The Motley Fool

2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026 ↗

September 02, 2026

Via The Motley Fool

CRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money? ↗

August 21, 2026

Via The Motley Fool

Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead ↗

August 20, 2026

Via The Motley Fool

Morgan Stanley Nearly Doubled Its Price Target for CRISPR Therapeutics. Is the Gene-Editing Stock a No-Brainer Buy? ↗

July 30, 2026

Via The Motley Fool

3 Stocks With the Most Upside by the End of 2026 ↗

July 30, 2026

Via The Motley Fool

3 Mid-Cap Growth Stocks With Monstrous Long-Term Upside ↗

July 28, 2026

Via The Motley Fool

Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating ↗

July 22, 2026

Via The Motley Fool

Cathie Wood Is Buying This Up-and-Coming Biotech Stock. Should You Follow Her Lead? ↗

July 20, 2026

Via The Motley Fool

3 Reasons to Buy CRISPR Therapeutics Stock ↗

July 10, 2026

Via The Motley Fool

Vertex’s Crinetics Deal Balances Growth with Integration Risk ↗

July 08, 2026

Via MarketBeat

A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics ↗

July 08, 2026

Via The Motley Fool

Over 2 Billion Reasons to Love CRISPR Therapeutics Right Now ↗

July 07, 2026

Via The Motley Fool

CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026? ↗

July 07, 2026

Via The Motley Fool

CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 06, 2026

Via The Motley Fool

CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ↗

June 27, 2026

Via The Motley Fool

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?

Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.

What exchange does CRISPR Therapeutics AG - Common Shares trade on?

CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?

The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market

What is the current price of CRISPR Therapeutics AG - Common Shares?

The current price of CRISPR Therapeutics AG - Common Shares is 54.23

When was CRISPR Therapeutics AG - Common Shares last traded?

The last trade of CRISPR Therapeutics AG - Common Shares was at 09/25/26 04:00 PM ET

What is the market capitalization of CRISPR Therapeutics AG - Common Shares?

The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.28B

How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?

CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.